maybe the triumph of hope over experience but i am feeling better about OSP's prospects:
- some serious cost cuts mean
- revenue growth will actually add to company value and
- the GE marketing deal offers the prospects of some pleasant surprises.
Hospitals will have to start getting back to treating usual patient case load sooner rather than later given patient needs and OSP's product is starting to look indispensable for patient care and keeping costs low.
- Forums
- ASX - By Stock
- OSP
- Ann: DyeVert featured at the SCAI 2020 Scientific Session
Ann: DyeVert featured at the SCAI 2020 Scientific Session, page-20
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online